Range
8.52 - 9.13
Vol / Avg.
2.1M/2.6M
Div / Yield
-
52 Wk
8.4 - 21.07
Mkt Cap
2.5B
Payout Ratio
-
Open
8.72
P/E
-
EPS
-0.19
Shares
278.6M
Outstanding
load more
Sector: Health Care.Industry: Biotechnology
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-28
REV
Q3 2021Est.ActualSurprise
EPS-0.180-0.190 -0.0100
REV80.110M79.545M-565.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Amicus Therapeutics Questions & Anwsers

Q

How do I buy Amicus Therapeutics (FOLD) stock?

A

You can purchase shares of Amicus Therapeutics (NASDAQ: FOLD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Amicus Therapeutics's (FOLD) competitors?

Q

What is the target price for Amicus Therapeutics (FOLD) stock?

A

The latest price target for Amicus Therapeutics (NASDAQ: FOLD) was reported by SVB Leerink on January 14, 2022. The analyst firm set a price target for 16.00 expecting FOLD to rise to within 12 months (a possible 75.25% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Amicus Therapeutics (FOLD)?

A

The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $9.13 last updated Fri Jan 28 2022 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Amicus Therapeutics (FOLD) pay a dividend?

A

There are no upcoming dividends for Amicus Therapeutics.

Q

When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?

A

Amicus Therapeutics’s $Q4 earnings are confirmed for after-market on February 28, 2022.

Q

Is Amicus Therapeutics (FOLD) going to split?

A

There is no upcoming split for Amicus Therapeutics.

Q

What sector and industry does Amicus Therapeutics (FOLD) operate in?

A

Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.